Primus Pharmaceuticals   Report issue

For profit Phase 1 Phase 3
Founded: Scottsdale AZ United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2005
NCT00626769
First Marketed Drug
2015
metaxalone (skelaxin)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Primus Pharmaceuticals,Inc | Primus Pharmaceuticals, Inc | PRIMUS PHARMS